What Humana (HUM) Said on Its Q3 Earnings Call
Humana (HUM) reported Medicare Stars results exceeding top-quartile goals for 2028, with a member-weighted rating of 4.17. The company plans to invest in Stars capabilities and pass some benefits to earnings. Medical cost trends for 2026 were lower than expected, while 2027 trends are projected at 8% to 9%. Humana also announced growth in CenterWell and Medicaid membership, a joint venture with BlackRock, and plans to sell its minority interest in Gentiva for $900 million.
How this was made
The 30-second read
Why it matters
The disclosed guidance and strategic moves could modestly affect Humana's valuation and peer comparisons in the health‑care sector.
Market read
First‑report earnings guidance for 2026‑2027 and strategic actions provide fresh data for traders evaluating Humana and the broader health‑care space.
What to watch
The joint venture with BlackRock reducing cost of capital may improve balance‑sheet strength, offsetting cost concerns.
Background
Humana's Q3 earnings call provided updates on Medicare Stars performance, cost trends, strategic joint venture, and asset disposition plans.
Ticker impact
Humana disclosed Q3 earnings call details, including a 4.17 Medicare Stars rating, cost trend guidance for 2026‑2027, a joint venture with BlackRock, and the planned sale of its Gentiva minority interest.
potential slight upside as market prices in better‑than‑expected cost trends, but pressure from higher Part D cost guidance may cap gains
New guidance on cost trends and strategic moves are primary disclosures that can shift valuation assumptions.
Market effects
Highlights continued pressure on Medicare Advantage cost structures, may influence peers in health insurance.
U.S. health‑care sector could see modest re‑rating based on Humana's cost outlook.
Limited to U.S. insurers; no direct global impact.
Counterpoint
Higher Part D cost guidance could signal rising expense pressure, suggesting caution despite the strong Stars rating.
Key entities
- companyHumana Inc.
U.S. health insurance and services provider.
- companyBlackRock
Asset manager partnering with Humana in a joint venture.
